Related Experiment Video
Updated: May 20, 2026
09:47
DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Alzheimer's disease: recent advances and future perspectives
1Department of Neurosciences, University of California, San Diego, CA 92093-0624, USA.
Journal of Alzheimer'S Disease : JAD
|July 20, 2012
Summary
Alzheimer's disease (AD) involves memory loss and cognitive decline due to neuron loss and protein buildup. Research focuses on understanding and clearing amyloid-beta and tau proteins for new Alzheimer's disease treatments.
Area of Science:
- Neurodegenerative Disorders
- Neuropathology
- Molecular Biology
Background:
- Alzheimer's disease (AD) is an age-related disorder causing progressive memory and cognitive deficits.
- Key neuropathological features include loss of basal forebrain cholinergic neurons and abnormal accumulation of amyloid-beta and tau proteins.
- Current research investigates the mechanisms of protein misfolding and accumulation in AD.
Purpose of the Study:
- To review current research areas in Alzheimer's disease.
- To explore therapeutic strategies targeting protein clearance and neuroprotection.
- To identify future research directions for AD.
Main Methods:
- Literature review of Alzheimer's disease research.
- Analysis of neuropathological mechanisms.
- Evaluation of experimental therapeutic approaches.
Main Results:
- Summarizes key findings on amyloid-beta and tau protein pathology.
- Highlights ongoing investigations into protein oligomerization and fibrillation.
- Discusses potential neuroprotective interventions.
Conclusions:
- Understanding protein accumulation dynamics is crucial for AD.
- Therapeutic strategies aim to clear misfolded proteins and offer neuroprotection.
- Further research is needed to develop effective treatments for Alzheimer's disease.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.